Merck

News

Merck, Pfizer covering bases with SGLT2 inhibitor latecomer

This year's American Diabetes Association conference takes place right next to San Diego's baseball stadium - and like the city's well-known Padres team, Merck and Pfizer are hoping to

Views & Analysis

Chicago, IL - 2016 ASCO Annual Meeting - Roomsets, signage and Generalviews during Thursday's set-up at the American Society of Clinical Oncology (ASCO) Annual Meeting here today, Thursday June 2, 2016. Over 30,000 physicians, researchers and healthcare professionals from over 100 countries are attending the 52nd Annual Meeting which is being held at the McCormick Place convention center. The Annual Meeting highlights the latest findings in all major areas of oncology from basic through clinical and epidemiological studies. Photo by © ASCO/Todd Buchanan 2016 Technical Questions: todd@medmeetingimages.com; ASCO Contact: photos@asco.org

ASCO 2017: Breast cancer next target for Keytruda

Immunotherapy combinations will be the focus - but attention is shifting towards these agents proving their overall survival benefits.

Views & Analysis

The cancer challenge: the quest for a cure is only half the ...

The cancer challenge is affecting more and more people worldwide, with 21 million cases expected by 2030.

News

Trump demands cuts to 'astronomical' drug prices - but pharm...

Trump calls pharma leaders to White House to discuss cutting taxes, regulations - and drug prices

ESMO2016

Cancer market commentary: Roche’s Tecentriq muscles into NSC...

Roche's PD-L1 drug has generated impressive data in second line lung cancer

ESMO2016

Eye on ESMO: Day Three - Merck & Co. wins big lung cancer ba...

Merck unveils impressive data on Keytruda, trumping BMS' Opdivo